Citations

Mayo Clinic

Showing 10 of 108537 citations.

Assessing the Inflammatory Landscape of Human Diabetic Kidney Disease (DKD) Through NanoString Digital Spatial Profiling Technology
Elhusseiny, Khaled , Bian, Xiaohui , Ma, Yaohua , Cornell, Lynn D. , Hickson, LaTonya J.

Journal of the American Society of Nephrology | May 17, 2024 | Volume: 33 | Issue: 11S | Pages: 116-116

10.1681/asn.20223311s1116a Get It

Genotype-Phenotype Correlation in Cystinuria
Cogal, Andrea G. , Porter, Ivan E. , Hossain, Mohammad Delwar , Goldfarb, David S. , Harris, Peter C. , Lieske, John C.

Journal of the American Society of Nephrology | May 17, 2024 | Volume: 33 | Issue: 11S | Pages: 761-761

10.1681/asn.20223311s1761a Get It

C3 Glomerulonephritis Has a Higher Burden of Complement Proteins Compared to Post-Infectious Glomerulonephritis
Theis, Jason D. , Holanda, Maria Izabel Neves de, Sethi, Sanjeev , Palma, Lilian Monteiro P , Fervenza, Fernando C.

Journal of the American Society of Nephrology | May 17, 2024 | Volume: 33 | Issue: 11S | Pages: 777-777

10.1681/asn.20223311s1777c Get It

Dialysis vs. Conservative Management for Patients 65 Years and Older With ESKD: A Propensity-Matched Cohort Study
Thorsteinsdottir, Bjoerg , Swarna, Kavya, Albright, Robert C. , O’Hare, Ann M. , Thorsteinsdottir, Bjorg , Rule, Andrew D. , Pálsson, Runólfur , Kashani, Kianoush , Hickson, LaTonya J.

Journal of the American Society of Nephrology | May 17, 2024 | Volume: 33 | Issue: 11S | Pages: 275-275

10.1681/asn.20223311s1275a Get It

Cadmium Toxicity From Cigarettes Causing Proximal Renal Tubular Acidosis and Severe Symptomatic Hypokalemia
Baker, Lyle W.

Journal of the American Society of Nephrology | May 17, 2024 | Volume: 33 | Issue: 11S | Pages: 741-741

10.1681/asn.20223311s1741b Get It

Race Independent eGFR Equations in Assessing Renal Function in Patients With Liver Disease
Meeusen, Jeff W., Dasari, Surendra , Dubourg, Laurence , Stämmler, Frank , Schiffer, Eric, Meeusen, Jeffrey W. , Lieske, John C. , Lemoine, Sandrine

Journal of the American Society of Nephrology | May 17, 2024 | Volume: 33 | Issue: 11S | Pages: 256-256

10.1681/asn.20223311s1256a Get It

Roxadustat vs. Erythropoiesis-Stimulating Agents and the Effect on Lipid Profile in Dialysis-Dependent Patients With Anemia of Renal Disease: A Meta-Analysis of Phase 3 Randomized Controlled Trials
Leelaviwat, Natnicha , Dejhansathit, Siroj , Duangkham, Samapon, Mekraksakit, Poemlarp , Rio‐Pertuz, Gaspar Del , Cheungpasitporn, Wisit , Benjanuwattra, Juthipong

Journal of the American Society of Nephrology | May 17, 2024 | Volume: 33 | Issue: 11S | Pages: 245-245

10.1681/asn.20223311s1245b Get It

Efficacy and Safety of Daprodustat for Treatment of Anemia in CKD: A Meta-Analysis
Khor, Si Yuan , Alattal, Sara, Kamboj, Amira S., Haddad, Issa R. , Turk, Michael , Garcilazo, Nora H. Hernandez , Hassanein, Mohamed , Al‐Abcha, Abdullah , Turk, Michael, Radhakrishnan, Yeshwanter , Hassanein, Mohamed

Journal of the American Society of Nephrology | May 17, 2024 | Volume: 33 | Issue: 11S | Pages: 243-243

10.1681/asn.20223311s1243b Get It

CKD Stage/Duration and Cardiovascular (CV) Risk Factors in Children With Proteinuric Glomerulopathies (GD)
Sethna, Christine B. , Meyers, Kevin , Srivastava, Tarak, Massengill, Susan F. , Weaver, Donald J. , Gibson, Keisha L. , Dell, Katherine M., Tran, Cheryl L. , Mitchell, Elizabeth , Tuttle, Katherine R. , Gipson, Debbie S , Trachtman, Howard

Journal of the American Society of Nephrology | May 17, 2024 | Volume: 33 | Issue: 11S | Pages: 215-215

10.1681/asn.20223311s1215b Get It

ADLM Guidance Document on the Measurement and Reporting of Lipids and Lipoproteins
Cao, Jing , El-Khoury, Joe M , Goldberg, Anne C. , Meeusen, Jeffrey W. , Remaley, Alan T. , Donato, Leslie, El-Khoury, Joe M , Donato, Leslie J.

The Journal of Applied Laboratory Medicine | May 17, 2024 | Volume: 9 | Issue: 5 | Pages: 1040-1056

10.1093/jalm/jfae057 | PMID 39225455 Get It

Abstract Background The accurate measurement of blood lipids and lipoproteins is crucial for the clinical management of atherosclerotic disease risk. Despite progress in standardization, there are still significant variations in pre-analytical requirements, methods, nomenclature, and reporting work flows. Content The guidance document aims to improve standardization of clinical lipid testing work flows. It provides recommendations for the components of the lipid panel, fasting requirements, reporting of results, and specific recommendations for non-high-density lipoprotein cholesterol (non-HDL-C), low-density lipoprotein cholesterol (LDL-C), lipoprotein(a) [Lp(a)], apolipoprotein B (apo B), point-of-care lipid testing, and LDL subfraction testing. Summary Lipid panels should always report non-HDL-C and LDL-C calculations if possible. Fasting is not routinely required except in specific cases. Modern equations should be utilized for LDL-C calculation. These equations allow for LDL-C reporting at elevated concentrations of triglycerides and obviate the need for direct measured LDL-C in most cases.